{"organizations": [], "uuid": "175f8082f150abfdc71909af995ca64dc8465bbd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180419.html", "section_title": "Archive News &amp; Video for Thursday, 19 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-onconova-presents-data-on-dual-inh/brief-onconova-presents-data-on-dual-inhibitor-of-cdk4-6-ark5-at-american-association-for-cancer-research-2018-annual-meeting-idUSFWN1RW0LS", "country": "US", "domain_rank": 408, "title": "BRIEF-Onconova Presents Data On Dual Inhibitor Of Cdk4/6 + Ark5 At American Association For Cancer Research 2018 Annual Meeting", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.541, "site_type": "news", "published": "2018-04-19T20:47:00.000+03:00", "replies_count": 0, "uuid": "175f8082f150abfdc71909af995ca64dc8465bbd"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-onconova-presents-data-on-dual-inh/brief-onconova-presents-data-on-dual-inhibitor-of-cdk4-6-ark5-at-american-association-for-cancer-research-2018-annual-meeting-idUSFWN1RW0LS", "ord_in_thread": 0, "title": "BRIEF-Onconova Presents Data On Dual Inhibitor Of Cdk4/6 + Ark5 At American Association For Cancer Research 2018 Annual Meeting", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "onconova therapeutics inc", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 19 (Reuters) - Onconova Therapeutics Inc:\n* ONCONOVA PRESENTS DATA ON DUAL INHIBITOR OF CDK4/6 + ARK5 AT AMERICAN ASSOCIATION FOR CANCER RESEARCH 2018 ANNUAL MEETING\n* ONCONOVA THERAPEUTICS INC - RECEIVES PRODUCTIVE PRE-IND GUIDANCE FROM FDA REGARDING FIRST-IN-CLASS COMPOUND ON 123300\n* ONCONOVA THERAPEUTICS INC - DEVELOPMENT PROGRAM IS IN COLLABORATION WITH HANX BIOPHARMACEUTICALS Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-19T20:47:00.000+03:00", "crawled": "2018-04-20T11:25:43.005+03:00", "highlightTitle": ""}